Industry-Leading Expertise in Preclinical Depression Studies

PsychoGenics leverages rigorous, well-validated testing methods to conduct the highest-quality preclinical depression studies for your innovative treatment. Rooted in a deep understanding of depression and its underlying mechanisms, PsychoGenics is equipped with a diverse range of preclinical tests designed to catalyze your research breakthroughs.

Validated Tests for Depression

PsychoGenics’ comprehensive battery of behavioral assessments offers a thorough preclinical evaluation of depressive-like behaviors and gauges the effectiveness of prospective treatments:

Effects of Imipramine and Ketamine on Social Interaction in Defeated Mice

Our studies at PsychoGenics also delve into the effects of Imipramine and Ketamine on social interaction in defeated mice. The results indicate that acute administration of Imipramine does not demonstrate efficacy in this model. However, when Imipramine is administered chronically (over 2 weeks), it significantly attenuates the social deficits observed in defeated mice. Conversely, an acute injection of Ketamine administered 24 hours prior to testing has been effective in attenuating social deficits in defeated mice. These findings are instrumental for our depression studies and early-stage depression research, highlighting potential pharmacological interventions for stress-induced social avoidance.

Effects of Double and Triple Reuptake Inhibitors

The triple uptake inhibitor DOV21947 and the double (serotonin / norepinephrine) reuptake inhibitor, venlafaxine, decrease immobility in the rat FS test following sub-chronic intraperitoneal injection.

Sertraline Decreases Time Immobile in BALB/cJ Mice

Sertraline, a Selective Serotonin Reuptake Inhibitor, decreases immobility of BALB/cJ mice in the FS test following acute intraperitoneal injection.